|Phone||+49 (0) 345 27 99 63 30|
|Venture Round, 2/11 |
Scil Proteins is a biopharmaceutical company discovering and developing AffilinÂ® molecules and working with industry partners in the development and manufacture of protein therapeutics and diagnostics. AffilinÂ® molecules are therapeutics and diagnostics based on a scaffold derived from the human protein Ubiquitin to form highly stable molecules with strong binding specificity and low immunogenicity. Scil Proteinsâ€™ discovery platform is a fully patent protected screening technology for the identification of target-specific AffilinÂ® molecules using advanced selection systems. Scil Proteins has generated a pipeline of AffilinÂ® therapeutics targeting cancer and other therapeutic areas. It also offers the technology to the industry for collaborative discovery and development partnerships. With a longstanding expertise in protein production and development, Scil Proteins also offers GMP contract biomanufacturing and process development to biotech and pharma companies. Scil Proteins is a well-established private company located in Halle, Germany.